Abstract Hormone binding controls the activity of estradiol receptor. The in vitro synthesized human receptor binds hormone with high affinity and low efficiency (1-4% of the maximal binding). We now report that phosphorylation on tyrosine of the synthetic receptor by an extensively purified calf uterus kinase increases hormone binding towards maximal levels without change in affinity. This is the first direct demonstration that a newly synthesized hormone receptor acquires ligand binding through phosphorylation. The use of in vitro synthesized proteins as substrates for enzymes which cause functional modifications of proteins is very promising because it is easy to identify the modified domains and residues by using deleted and point muta...
The estrogen receptor (ER) is the number one target for the treatment of endocrine responsive breast...
Abstract The effect of phosphorylation on the hormone-binding capacity of the estrogen receptor (ER...
The estrogen receptor (ER) is the number one target for the treatment of endocrine responsive breast...
Abstract Hormone binding controls the activity of estradiol receptor. The in vitro synthesized huma...
Abstract A tyrosine kinase purified from calf uterus activates the hormone binding of endogenous es...
Abstract Recent experiments have shown that calf uterus oestrogen receptor exists in a tyrosine-pho...
Abstract A uterus tyrosine kinase has been purified to a single 67-kDa protein when analyzed by SDS...
The calf uterus oestradiol-17 beta receptor exists in a hormone binding form, which is phosphorylate...
Steriod hormones regulate differentiation and proliferation of several cell types. They interact wi...
We have shown with in vitro experiments that uterus estradiol receptor undergoes dephosphorylation b...
Studies were undertaken to examine the interaction of estrogen agonists and antagonists with the hum...
Chemical protein synthesis allows the generation of milligram quantities of correctly folded and pre...
textabstractAll members of the steroid hormone receptor family are phosphoproteins. Additional phosp...
In this manuscript, we modulate the binding properties of estrogen receptor protein by rationally mo...
In this manuscript, we modulate the binding properties of estrogen receptor protein by rationally mo...
The estrogen receptor (ER) is the number one target for the treatment of endocrine responsive breast...
Abstract The effect of phosphorylation on the hormone-binding capacity of the estrogen receptor (ER...
The estrogen receptor (ER) is the number one target for the treatment of endocrine responsive breast...
Abstract Hormone binding controls the activity of estradiol receptor. The in vitro synthesized huma...
Abstract A tyrosine kinase purified from calf uterus activates the hormone binding of endogenous es...
Abstract Recent experiments have shown that calf uterus oestrogen receptor exists in a tyrosine-pho...
Abstract A uterus tyrosine kinase has been purified to a single 67-kDa protein when analyzed by SDS...
The calf uterus oestradiol-17 beta receptor exists in a hormone binding form, which is phosphorylate...
Steriod hormones regulate differentiation and proliferation of several cell types. They interact wi...
We have shown with in vitro experiments that uterus estradiol receptor undergoes dephosphorylation b...
Studies were undertaken to examine the interaction of estrogen agonists and antagonists with the hum...
Chemical protein synthesis allows the generation of milligram quantities of correctly folded and pre...
textabstractAll members of the steroid hormone receptor family are phosphoproteins. Additional phosp...
In this manuscript, we modulate the binding properties of estrogen receptor protein by rationally mo...
In this manuscript, we modulate the binding properties of estrogen receptor protein by rationally mo...
The estrogen receptor (ER) is the number one target for the treatment of endocrine responsive breast...
Abstract The effect of phosphorylation on the hormone-binding capacity of the estrogen receptor (ER...
The estrogen receptor (ER) is the number one target for the treatment of endocrine responsive breast...